메뉴 건너뛰기




Volumn 2014, Issue , 2014, Pages

Hypofractionation in prostate cancer: Radiobiological basis and clinical appliance

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; CANCER CONTROL; CANCER GRADING; CANCER RADIOTHERAPY; COBALT-60 UNIT; COMPUTER ASSISTED RADIOTHERAPY; CYBERKNIFE; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE QUALITY; HUMAN; HYPOFRACTIONATED RADIOTHERAPY; HYPOFRACTIONATION; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; METASTASIS FREE SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); PROGRESSION FREE SURVIVAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE ESCALATION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOBIOLOGY; RADIOLOGICAL PARAMETERS; RADIOSENSITIVITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; THREE DIMENSIONAL IMAGING; MALE; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; RADIOSURGERY;

EID: 84901750086     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/781340     Document Type: Review
Times cited : (20)

References (64)
  • 4
    • 77949509341 scopus 로고    scopus 로고
    • Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09
    • 2-s2.0-77949509341 10.1200/JCO.2009.25.8475
    • Zietman A. L., Bae K., Slater J. D., Shipley W. U., Efstathiou J. A., Coen J. J., Bush D. A., Lunt M., Spiegel D. Y., Skowronski R., Jabola B. R., Rossi C. J., Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from Proton Radiation Oncology Group/American College Of Radiology 95-09. Journal of Clinical Oncology 2010 28 7 1106 1111 2-s2.0-77949509341 10.1200/JCO.2009.25.8475
    • (2010) Journal of Clinical Oncology , vol.28 , Issue.7 , pp. 1106-1111
    • Zietman, A.L.1    Bae, K.2    Slater, J.D.3    Shipley, W.U.4    Efstathiou, J.A.5    Coen, J.J.6    Bush, D.A.7    Lunt, M.8    Spiegel, D.Y.9    Skowronski, R.10    Jabola, B.R.11    Rossi, C.J.12
  • 5
    • 0021879466 scopus 로고
    • Biologic basis for altered fractionation schemes
    • Withers H. R., Biologic basis for altered fractionation schemes. Cancer 1985 55 supplement 9 2086 2095 2-s2.0-0021879466 (Pubitemid 15077682)
    • (1985) Cancer , vol.55 , Issue.9 SUPPL. , pp. 2086-2095
    • Withers, H.R.1
  • 6
    • 0020064973 scopus 로고
    • Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships
    • Thames H. D. Jr., Withers H. R., Peters L. J., Fletcher G. H., Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. International Journal of Radiation, Oncology, Biology Physics 1982 8 2 219 226 2-s2.0-0020064973 (Pubitemid 12139897)
    • (1982) International Journal of Radiation Oncology Biology Physics , vol.8 , Issue.2 , pp. 219-226
    • Thames Jr., H.D.1    Withers, H.R.2    Peters, L.J.3    Fletcher, G.H.4
  • 7
    • 0024358259 scopus 로고
    • The linear-quadratic formula and progress in fractionated radiotherapy
    • Fowler J. F., The linear-quadratic formula and progress in fractionated radiotherapy. British Journal of Radiology 1989 62 740 679 694 2-s2.0-0024358259 (Pubitemid 19194494)
    • (1989) British Journal of Radiology , vol.62 , Issue.740 , pp. 679-694
    • Fowler, J.F.1
  • 8
    • 79955722555 scopus 로고    scopus 로고
    • Isoeffect calculations with the linear quadratic and its extensions: An examination of model-dependent estimates at doses relevant to hypofractionation
    • 2-s2.0-79955722555 10.4103/0971-6203.79689
    • McKenna F., Ahmad S., Isoeffect calculations with the linear quadratic and its extensions: an examination of model-dependent estimates at doses relevant to hypofractionation. Journal of Medical Physics 2011 36 2 100 106 2-s2.0-79955722555 10.4103/0971-6203.79689
    • (2011) Journal of Medical Physics , vol.36 , Issue.2 , pp. 100-106
    • McKenna, F.1    Ahmad, S.2
  • 10
    • 0032913909 scopus 로고    scopus 로고
    • Fractionation and protraction for radiotherapy of prostate carcinoma
    • DOI 10.1016/S0360-3016(98)00438-6, PII S0360301698004386
    • Brenner D. J., Hall E. J., Fractionation and protraction for radiotherapy of prostate carcinoma. International Journal of Radiation, Oncology, Biology Physics 1999 43 5 1095 1101 2-s2.0-0032913909 10.1016/S0360-3016(98)00438-6 (Pubitemid 29144800)
    • (1999) International Journal of Radiation Oncology Biology Physics , vol.43 , Issue.5 , pp. 1095-1101
    • Brenner, D.J.1    Hall, E.J.2
  • 11
    • 5744247185 scopus 로고    scopus 로고
    • Comparison of in vitro and in vivo α/β ratios for prostate cancer
    • DOI 10.1088/0031-9155/49/19/003, PII S0031915504827076
    • Carlson D. J., Stewart R. D., Li X. A., Jennings K., Wang J. Z., Guerrero M., Comparison of in vitro and in vivo α / β ratios for prostate cancer. Physics in Medicine and Biology 2004 49 19 4477 4491 2-s2.0-5744247185 10.1088/0031-9155/49/19/003 (Pubitemid 39378241)
    • (2004) Physics in Medicine and Biology , vol.49 , Issue.19 , pp. 4477-4491
    • Carlson, D.J.1    Stewart, R.D.2    Li, X.A.3    Jennings, K.4    Wang, J.Z.5    Guerrero, M.6
  • 12
    • 49749121119 scopus 로고    scopus 로고
    • The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery
    • 2-s2.0-49749121119 10.1016/j.semradonc.2008.04.005
    • Kirkpatrick J. P., Meyer J. J., Marks L. B., The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Seminars in Radiation Oncology 2008 18 4 240 243 2-s2.0-49749121119 10.1016/j.semradonc.2008.04.005
    • (2008) Seminars in Radiation Oncology , vol.18 , Issue.4 , pp. 240-243
    • Kirkpatrick, J.P.1    Meyer, J.J.2    Marks, L.B.3
  • 14
    • 0001086274 scopus 로고
    • The four R's of radiotherapy
    • New York, NY, USA Academic Press
    • Withers H. R., Lett J. T., Adler H., The four R's of radiotherapy. Advances in Radiation Biology 1975 5 New York, NY, USA Academic Press 241 271
    • (1975) Advances in Radiation Biology , vol.5 , pp. 241-271
    • Withers, H.R.1    Lett, J.T.2    Adler, H.3
  • 15
    • 0015622754 scopus 로고
    • Changes in the rate of repopulation during multifraction irradiation of mouse skin
    • 2-s2.0-0015622754
    • Denekamp J., Changes in the rate of repopulation during multifraction irradiation of mouse skin. British Journal of Radiology 1973 46 545 381 387 2-s2.0-0015622754
    • (1973) British Journal of Radiology , vol.46 , Issue.545 , pp. 381-387
    • Denekamp, J.1
  • 16
    • 0021645799 scopus 로고
    • Fractionated radiation therappy after Strandqvist
    • Fowler J. F., Fractionated radiation therappy after Strandqvist. Acta Radiologica Oncology 1984 23 4 209 216 2-s2.0-0021645799 (Pubitemid 15072793)
    • (1984) Acta Radiologica Oncology , vol.23 , Issue.4 , pp. 209-216
    • Fowler, J.F.1
  • 17
    • 0025838346 scopus 로고
    • Clinical evidence for tumor clonogen regeneration: Interpretations of the data
    • 2-s2.0-0025838346 10.1016/0167-8140(91)90019-D
    • Bentzen S. M., Thames H. D., Clinical evidence for tumor clonogen regeneration: interpretations of the data. Radiotherapy & Oncology 1991 22 3 161 166 2-s2.0-0025838346 10.1016/0167-8140(91)90019-D
    • (1991) Radiotherapy & Oncology , vol.22 , Issue.3 , pp. 161-166
    • Bentzen, S.M.1    Thames, H.D.2
  • 18
    • 0023894783 scopus 로고
    • The hazard of accelerated tumor clonogen repopulation during radiotherapy
    • 2-s2.0-0023894783
    • Whithers H. R., Taylor J. M., Maciejewski B., The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncologica 1988 27 2 131 146 2-s2.0-0023894783
    • (1988) Acta Oncologica , vol.27 , Issue.2 , pp. 131-146
    • Whithers, H.R.1    Taylor, J.M.2    Maciejewski, B.3
  • 19
    • 0022629891 scopus 로고
    • Cell kinetics and radiation biology
    • Denekamp J., Cell kinetics and radiation biology. International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine 1986 49 2 357 380 10.1080/09553008514552591 (Pubitemid 16182969)
    • (1986) International Journal of Radiation Biology , vol.49 , Issue.2 , pp. 357-380
    • Denekamp, J.1
  • 21
    • 0020064973 scopus 로고
    • Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships
    • Thames H. D. Jr., Withers H. R., Peters L. J., Fletcher G. H., Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. International Journal of Radiation, Oncology, Biology Physics 1982 8 2 219 226 2-s2.0-0020064973 (Pubitemid 12139897)
    • (1982) International Journal of Radiation Oncology Biology Physics , vol.8 , Issue.2 , pp. 219-226
    • Thames Jr., H.D.1    Withers, H.R.2    Peters, L.J.3    Fletcher, G.H.4
  • 22
    • 49749100424 scopus 로고    scopus 로고
    • Clinical experience using hypofractionated radiation schedules in breast cancer
    • 2-s2.0-49749100424 10.1016/j.semradonc.2008.04.008
    • Whelan T. J., Kim D. H., Sussman J., Clinical experience using hypofractionated radiation schedules in breast cancer. Seminars in Radiation Oncology 2008 18 4 257 264 2-s2.0-49749100424 10.1016/j.semradonc.2008.04.008
    • (2008) Seminars in Radiation Oncology , vol.18 , Issue.4 , pp. 257-264
    • Whelan, T.J.1    Kim, D.H.2    Sussman, J.3
  • 23
    • 33646862836 scopus 로고    scopus 로고
    • Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial
    • DOI 10.1016/S1470-2045(06)70699-4, PII S1470204506706994
    • Owen J. R., Ashton A., Bliss J. M., Homewood J., Harper C., Hanson J., Haviland J., Bentzen S. M., Yarnold J. R., Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. The Lancet Oncology 2006 7 6 467 471 2-s2.0-33646862836 10.1016/S1470-2045(06)70699-4 (Pubitemid 43779171)
    • (2006) Lancet Oncology , vol.7 , Issue.6 , pp. 467-471
    • Owen, J.R.1    Ashton, A.2    Bliss, J.M.3    Homewood, J.4    Harper, C.5    Hanson, J.6    Haviland, J.7    Bentzen, S.M.8    Yarnold, J.R.9
  • 24
    • 0035879455 scopus 로고    scopus 로고
    • Is α/β for prostate tumors really low?
    • DOI 10.1016/S0360-3016(01)01607-8, PII S0360301601016078
    • Fowler J. F., Chappell R., Ritter M., Is α / β for prostate tumors really low? International Journal of Radiation, Oncology, Biology Physics 2001 50 4 1021 1031 2-s2.0-0035879455 10.1016/S0360-3016(01)01607-8 (Pubitemid 32594841)
    • (2001) International Journal of Radiation Oncology Biology Physics , vol.50 , Issue.4 , pp. 1021-1031
    • Fowler, J.1    Chappell, R.2    Ritter, M.3
  • 25
    • 83955161787 scopus 로고    scopus 로고
    • Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α / β = 1.4 (0.9-2.2) Gy
    • 2-s2.0-83955161787 10.1016/j.ijrobp.2010.10.075
    • Miralbell R., Roberts S. A., Zubizarreta E., Hendry J. H., Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α / β = 1.4 (0.9-2.2) Gy. International Journal of Radiation Oncology Biology Physics 2012 82 1 e17 e24 2-s2.0-83955161787 10.1016/j.ijrobp.2010.10. 075
    • (2012) International Journal of Radiation Oncology Biology Physics , vol.82 , Issue.1
    • Miralbell, R.1    Roberts, S.A.2    Zubizarreta, E.3    Hendry, J.H.4
  • 26
    • 0037215315 scopus 로고    scopus 로고
    • How low is the α/β ratio for prostate cancer?
    • DOI 10.1016/S0360-3016(02)03828-2, PII S0360301602038282
    • Wang J. Z., Guerrero M., Li X. A., How low is the α / β ratio for prostate cancer? International Journal of Radiation Oncology Biology Physics 2003 55 1 194 203 10.1016/S0360-3016(02)03828-2 (Pubitemid 36020360)
    • (2003) International Journal of Radiation Oncology Biology Physics , vol.55 , Issue.1 , pp. 194-203
    • Wang, J.Z.1    Guerrero, M.2    Li, X.A.3
  • 27
    • 0142186650 scopus 로고    scopus 로고
    • How low is the α/β ratio for prostate cancer?
    • DOI 10.1016/S0360-3016(03)01455-X
    • Kal H., van Gellekom M. P., How low is the α / β ratio for prostate cancer? International Journal of Radiation, Oncology, Biology Physics 2003 57 4 1116 1121 2-s2.0-0142186650 10.1016/S0360-3016(03)01455-X (Pubitemid 37324131)
    • (2003) International Journal of Radiation Oncology Biology Physics , vol.57 , Issue.4 , pp. 1116-1121
    • Kal, H.B.1    Van Gellekom, M.P.R.2
  • 28
    • 0034183792 scopus 로고    scopus 로고
    • Is the prostate α/β ratio of 1.5 from Brenner and Hall a modeling artifact? [2]
    • DOI 10.1016/S0360-3016(00)00442-9, PII S0360301600004429
    • King C. R., Mayo C. S., Is the prostate α / β ratio of 1.5 from Brenner and Hall a modeling artifact? International Journal of Radiation, Oncology, Biology Physics 2000 47 2 536 539 2-s2.0-0034183792 10.1016/S0360-3016(00)00442-9 (Pubitemid 30236399)
    • (2000) International Journal of Radiation Oncology Biology Physics , vol.47 , Issue.2 , pp. 536-539
    • King, C.R.1    Mayo, C.S.2
  • 29
    • 84875276506 scopus 로고    scopus 로고
    • Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer
    • 10.1016/j.ijrobp.2012.11.033
    • Pedicini P., Strigari L., Benassi M., Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer. International Journal of Radiation, Oncology, Biology Physics 2013 85 5 e231 e237 10.1016/j.ijrobp.2012.11.033
    • (2013) International Journal of Radiation, Oncology, Biology Physics , vol.85 , Issue.5
    • Pedicini, P.1    Strigari, L.2    Benassi, M.3
  • 30
    • 84881557290 scopus 로고    scopus 로고
    • Systematic review of hypofractionated radiation therapy for prostate cancer
    • 10.1016/j.ctrv.2013.01.008
    • Zaorsky N. G., Ohri N., Showalter T. N., Dicker A. P., Den R. B., Systematic review of hypofractionated radiation therapy for prostate cancer. Cancer Treatment Reviews 2013 39 7 728 736 10.1016/j.ctrv.2013.01.008
    • (2013) Cancer Treatment Reviews , vol.39 , Issue.7 , pp. 728-736
    • Zaorsky, N.G.1    Ohri, N.2    Showalter, T.N.3    Dicker, A.P.4    Den, R.B.5
  • 31
    • 0025313292 scopus 로고
    • Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984)
    • DOI 10.1016/0090-4295(90)80207-4
    • Lloyd-Davies R. W., Collins C. D., Swan A. V., Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984). Urology 1990 36 2 107 111 2-s2.0-0025313292 10.1016/0090-4295(90)80207-4 (Pubitemid 20239018)
    • (1990) Urology , vol.36 , Issue.2 , pp. 107-111
    • Lloyd-Davies, R.W.1    Collins, C.D.2    Swan, A.V.3
  • 32
    • 0026165938 scopus 로고
    • Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique
    • 2-s2.0-0026165938
    • Collins C. D., Lloyd-Davies R. W., Swan A. V., Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique. Clinical Oncology 1991 3 3 127 132 2-s2.0-0026165938
    • (1991) Clinical Oncology , vol.3 , Issue.3 , pp. 127-132
    • Collins, C.D.1    Lloyd-Davies, R.W.2    Swan, A.V.3
  • 34
    • 33750297651 scopus 로고    scopus 로고
    • Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: Updated results of a phase III randomized trial
    • DOI 10.1016/j.ijrobp.2006.06.005, PII S0360301606009813
    • Yeoh E. E., Holloway R. H., Fraser R. J., Botten R. J., di Matteo A. C., Butters J., Weerasinghe S., Abeysinghe P., Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial. International Journal of Radiation, Oncology, Biology Physics 2006 66 4 1072 1083 2-s2.0-33750297651 10.1016/j.ijrobp.2006.06.005 (Pubitemid 44633501)
    • (2006) International Journal of Radiation Oncology Biology Physics , vol.66 , Issue.4 , pp. 1072-1083
    • Yeoh, E.E.1    Holloway, R.H.2    Fraser, R.J.3    Botten, R.J.4    Di Matteo, A.C.5    Butters, J.6    Weerasinghe, S.7    Abeysinghe, P.8
  • 35
    • 81855185482 scopus 로고    scopus 로고
    • Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: Final results of phase III randomized trial
    • 2-s2.0-81855185482 10.1016/j.ijrobp.2010.07.1984
    • Yeoh E. E., Botten R. J., Butters J., di Matteo A. C., Holloway R. H., Fowler J., Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial. International Journal of Radiation Oncology Biology Physics 2011 81 5 1271 1278 2-s2.0-81855185482 10.1016/j.ijrobp.2010.07.1984
    • (2011) International Journal of Radiation Oncology Biology Physics , vol.81 , Issue.5 , pp. 1271-1278
    • Yeoh, E.E.1    Botten, R.J.2    Butters, J.3    Di Matteo, A.C.4    Holloway, R.H.5    Fowler, J.6
  • 37
    • 37449026934 scopus 로고    scopus 로고
    • The phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer
    • 2-s2.0-37449026934 10.1002/cncr.23139
    • Abramowitz M. C., Li T., Buyyounouski M. K., Ross E., Uzzo R. G., Pollack A., Horwitz E. M., The phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer 2008 112 1 55 60 2-s2.0-37449026934 10.1002/cncr.23139
    • (2008) Cancer , vol.112 , Issue.1 , pp. 55-60
    • Abramowitz, M.C.1    Li, T.2    Buyyounouski, M.K.3    Ross, E.4    Uzzo, R.G.5    Pollack, A.6    Horwitz, E.M.7
  • 38
    • 20144373530 scopus 로고    scopus 로고
    • Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
    • DOI 10.1038/sj.bjc.6602301
    • Dearnaley D. P., Hall E., Lawrence D., Huddart R. A., Eeles R., Nutting C. M., Gadd J., Warrington A., Bidmead M., Horwich A., Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. British Journal of Cancer 2005 92 3 488 498 2-s2.0-20144373530 10.1038/sj.bjc.6602301 (Pubitemid 40395529)
    • (2005) British Journal of Cancer , vol.92 , Issue.3 , pp. 488-498
    • Dearnaley, D.P.1    Hall, E.2    Lawrence, D.3    Huddart, R.A.4    Eeles, R.5    Nutting, C.M.6    Gadd, J.7    Warrington, A.8    Bidmead, M.9    Horwich, A.10
  • 39
    • 34047159109 scopus 로고    scopus 로고
    • The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: Results from the MRC RT01 trial (ISRCTN47772397)
    • DOI 10.1016/j.radonc.2007.02.014, PII S0167814007000837
    • Dearnaley D. P., Sydes M. R., Langley R. E., Graham J. D., Huddart R. A., Syndikus I., Matthews J. H. L., Scrase C. D., Jose C. C., Logue J., Stephens R. J., The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397). Radiotherapy & Oncology 2007 83 1 31 41 2-s2.0-34047159109 10.1016/j.radonc.2007.02.014 (Pubitemid 46527948)
    • (2007) Radiotherapy and Oncology , vol.83 , Issue.1 , pp. 31-41
    • Dearnaley, D.P.1    Sydes, M.R.2    Langley, R.E.3    Graham, J.D.4    Huddart, R.A.5    Syndikus, I.6    Matthews, J.H.L.7    Scrase, C.D.8    Jose, C.C.9    Logue, J.10    Stephens, R.J.11
  • 40
    • 19944431984 scopus 로고    scopus 로고
    • Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: The combined experience of nine institutions in patients treated in 1994 and 1995
    • DOI 10.1016/j.ijrobp.2004.05.018, PII S036030160400817X
    • Kupelian P., Kuban D., Thames H., Levy L., Horwitz E., Martinez A., Michalski J., Pisansky T., Sandler H., Shipley W., Zelefsky M., Zietman A., Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. International Journal of Radiation, Oncology, Biology Physics 2005 61 2 415 419 2-s2.0-19944431984 10.1016/j.ijrobp.2004.05.018 (Pubitemid 40164435)
    • (2005) International Journal of Radiation Oncology Biology Physics , vol.61 , Issue.2 , pp. 415-419
    • Kupelian, P.1    Kuban, D.2    Thames, H.3    Levy, L.4    Horwitz, E.5    Martinez, A.6    Michalski, J.7    Pisansky, T.8    Sandler, H.9    Shipley, W.10    Zelefsky, M.11    Zietman, A.12
  • 42
    • 33646462895 scopus 로고    scopus 로고
    • Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy
    • DOI 10.1200/JCO.2005.05.2530
    • Peeters S. T., Heemsbergen W. D., Koper P. C. M., van Putten W. L. J., Slot A., Dielwart M. F. H., Bonfrer J. M. G., Incrocci L., Lebesque J. V., Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. Journal of Clinical Oncology 2006 24 13 1990 1996 2-s2.0-33646462895 10.1200/JCO.2005.05.2530 (Pubitemid 46622106)
    • (2006) Journal of Clinical Oncology , vol.24 , Issue.13 , pp. 1990-1996
    • Peeters, S.T.H.1    Heemsbergen, W.D.2    Koper, P.C.M.3    Van Putten, W.L.J.4    Slot, A.5    Dielwart, M.F.H.6    Bonfrer, J.M.G.7    Incrocci, L.8    Lebesque, J.V.9
  • 43
    • 45449093563 scopus 로고    scopus 로고
    • Long-term results of conformal radiotherapy for prostate cancer: Impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes
    • 2-s2.0-45449093563 10.1016/j.ijrobp.2007.11.066
    • Zelefsky M. J., Yamada Y., Fuks Z., Zhang Z., Hunt M., Cahlon O., Park J., Shippy A., Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. International Journal of Radiation, Oncology, Biology Physics 2008 71 4 1028 1033 2-s2.0-45449093563 10.1016/j.ijrobp.2007. 11.066
    • (2008) International Journal of Radiation, Oncology, Biology Physics , vol.71 , Issue.4 , pp. 1028-1033
    • Zelefsky, M.J.1    Yamada, Y.2    Fuks, Z.3    Zhang, Z.4    Hunt, M.5    Cahlon, O.6    Park, J.7    Shippy, A.8
  • 44
    • 77953961599 scopus 로고    scopus 로고
    • A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer
    • 10.1016/j.ijrobp.2009.07.1691
    • Arcangeli G., Saracino B., Gomellini S., A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. International Journal of Radiation, Oncology, Biology Physics 2010 78 1 11 18 10.1016/j.ijrobp.2009.07.1691
    • (2010) International Journal of Radiation, Oncology, Biology Physics , vol.78 , Issue.1 , pp. 11-18
    • Arcangeli, G.1    Saracino, B.2    Gomellini, S.3
  • 45
    • 79951953933 scopus 로고    scopus 로고
    • Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer
    • 2-s2.0-79951953933 10.1016/j.ijrobp.2009.12.045
    • Arcangeli G., Fowler J., Gomellini S., Arcangeli S., Saracino B., Petrongari M. G., Benassi M., Strigari L., Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer. International Journal of Radiation, Oncology, Biology Physics 2011 79 4 1013 1021 2-s2.0-79951953933 10.1016/j.ijrobp.2009.12.045
    • (2011) International Journal of Radiation, Oncology, Biology Physics , vol.79 , Issue.4 , pp. 1013-1021
    • Arcangeli, G.1    Fowler, J.2    Gomellini, S.3    Arcangeli, S.4    Saracino, B.5    Petrongari, M.G.6    Benassi, M.7    Strigari, L.8
  • 47
    • 84855302012 scopus 로고    scopus 로고
    • Preliminary report of a randomized dose escalation trial for prostate cancer using hypofractionation
    • 10.1016/j.ijrobp.2010.07.170
    • Kuban D. A., Nogueras-Gonzalez G. M., Hamblin L., Preliminary report of a randomized dose escalation trial for prostate cancer using hypofractionation. International Journal of Radiation Oncology, Biology, Physics 2010 78 3, supplement S58 S59 10.1016/j.ijrobp.2010.07.170
    • (2010) International Journal of Radiation Oncology, Biology, Physics , vol.78 , Issue.3 SUPPL.
    • Kuban, D.A.1    Nogueras-Gonzalez, G.M.2    Hamblin, L.3
  • 48
    • 84891606493 scopus 로고    scopus 로고
    • Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer
    • 10.1200/JCO.2013.51.1972
    • Pollack A., Walker G., Horwitz E. M., Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. Journal of Clinical Oncology 2013 31 31 3860 3868 10.1200/JCO.2013.51.1972
    • (2013) Journal of Clinical Oncology , vol.31 , Issue.31 , pp. 3860-3868
    • Pollack, A.1    Walker, G.2    Horwitz, E.M.3
  • 49
    • 34547431049 scopus 로고    scopus 로고
    • Hypofractionated Intensity-Modulated Radiotherapy (70 Gy at 2.5 Gy Per Fraction) for Localized Prostate Cancer: Cleveland Clinic Experience
    • DOI 10.1016/j.ijrobp.2007.01.067, PII S0360301607005354
    • Kupelian P. A., Willoughby T. R., Reddy C. A., Klein E. A., Mahadevan A., Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: cleveland clinic experience. International Journal of Radiation, Oncology, Biology Physics 2007 68 5 1424 1430 2-s2.0-34547431049 10.1016/j.ijrobp.2007.01.067 (Pubitemid 47176809)
    • (2007) International Journal of Radiation Oncology Biology Physics , vol.68 , Issue.5 , pp. 1424-1430
    • Kupelian, P.A.1    Willoughby, T.R.2    Reddy, C.A.3    Klein, E.A.4    Mahadevan, A.5
  • 51
    • 33747176013 scopus 로고    scopus 로고
    • High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer
    • DOI 10.1016/j.radonc.2006.06.011, PII S0167814006002532
    • Yoshioka Y., Konishi K., Oh R.-J., Sumida I., Yamazaki H., Nakamura S., Nishimura K., Nonomura N., Okuyama A., Inoue T., High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer. Radiotherapy & Oncology 2006 80 1 62 68 2-s2.0-33747176013 10.1016/j.radonc.2006.06.011 (Pubitemid 44226435)
    • (2006) Radiotherapy and Oncology , vol.80 , Issue.1 , pp. 62-68
    • Yoshioka, Y.1    Konishi, K.2    Oh, R.-J.3    Sumida, I.4    Yamazaki, H.5    Nakamura, S.6    Nishimura, K.7    Nonomura, N.8    Okuyama, A.9    Inoue, T.10
  • 55
    • 51449100864 scopus 로고    scopus 로고
    • A phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer
    • 2-s2.0-51449100864 10.1016/j.ijrobp.2007.12.026
    • Corner C., Rojas A. M., Bryant L., Ostler P., Hoskin P., A phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer. International Journal of Radiation, Oncology, Biology Physics 2008 72 2 441 446 2-s2.0-51449100864 10.1016/j.ijrobp.2007.12. 026
    • (2008) International Journal of Radiation, Oncology, Biology Physics , vol.72 , Issue.2 , pp. 441-446
    • Corner, C.1    Rojas, A.M.2    Bryant, L.3    Ostler, P.4    Hoskin, P.5
  • 56
    • 84873994847 scopus 로고    scopus 로고
    • Stereotactic body radiation therapy for prostate cancer: Is the technology ready to be the standard of care?
    • 10.1016/j.ctrv.2012.10.003
    • Zaorsky N. G., Studenski M. T., Dicker A. P., Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care? Cancer Treatment Reviews 2013 39 3 212 218 10.1016/j.ctrv.2012.10.003
    • (2013) Cancer Treatment Reviews , vol.39 , Issue.3 , pp. 212-218
    • Zaorsky, N.G.1    Studenski, M.T.2    Dicker, A.P.3
  • 57
    • 33847248003 scopus 로고    scopus 로고
    • Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results
    • 2-s2.0-33847248003 10.1016/j.ijrobp.2006.10.050
    • Madsen B. L., Hsi R. A., Pham H. T., Fowler J. F., Esagui L., Corman J., Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. International Journal of Radiation, Oncology, Biology Physics 2007 67 4 1099 1105 2-s2.0-33847248003 10.1016/j.ijrobp.2006.10.050
    • (2007) International Journal of Radiation, Oncology, Biology Physics , vol.67 , Issue.4 , pp. 1099-1105
    • Madsen, B.L.1    Hsi, R.A.2    Pham, H.T.3    Fowler, J.F.4    Esagui, L.5    Corman, J.6
  • 58
    • 55149089265 scopus 로고    scopus 로고
    • Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localized prostate cancer: Early results of pHART3
    • 2-s2.0-55149089265 10.1016/j.clon.2008.08.006
    • Tang C. I., Loblaw D. A., Cheung P., Holden L., Morton G., Basran P. S., Tirona R., Cardoso M., Pang G., Gardner S., Cesta A., Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localized prostate cancer: early results of pHART3. Clinical Oncology 2008 20 10 729 737 2-s2.0-55149089265 10.1016/j.clon.2008.08.006
    • (2008) Clinical Oncology , vol.20 , Issue.10 , pp. 729-737
    • Tang, C.I.1    Loblaw, D.A.2    Cheung, P.3    Holden, L.4    Morton, G.5    Basran, P.S.6    Tirona, R.7    Cardoso, M.8    Pang, G.9    Gardner, S.10    Cesta, A.11
  • 60
    • 84873996862 scopus 로고    scopus 로고
    • Stereotactic body radiation therapy for low-, intermediate- and high-risk prostate cancer: Disease control and quality of life
    • Katz A. J., Santoro M., DiBlasio F., Stereotactic body radiation therapy for low-, intermediate- and high-risk prostate cancer: disease control and quality of life. International Journal of Radiation, Oncology, Biology Physics 2011 81 2, supplement S100
    • (2011) International Journal of Radiation, Oncology, Biology Physics , vol.81 , Issue.2 SUPPL.
    • Katz, A.J.1    Santoro, M.2    Diblasio, F.3
  • 62
    • 78650982500 scopus 로고    scopus 로고
    • Stereotactic body radiotherapy for low-risk prostate cancer: Five-year outcomes
    • 2-s2.0-78650982500 10.1186/1748-717X-6-3
    • Freeman D. E., King C. R., Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes. Radiation Oncology 2011 6 1, article 3 2-s2.0-78650982500 10.1186/1748-717X-6-3
    • (2011) Radiation Oncology , vol.6 , Issue.1
    • Freeman, D.E.1    King, C.R.2
  • 63
    • 84855825726 scopus 로고    scopus 로고
    • Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer
    • 2-s2.0-84855825726 10.1016/j.ijrobp.2010.11.054
    • King C. R., Brooks J. D., Gill H., Presti J. C. Jr., Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. International Journal of Radiation, Oncology, Biology Physics 2012 82 2 877 882 2-s2.0-84855825726 10.1016/j.ijrobp.2010.11.054
    • (2012) International Journal of Radiation, Oncology, Biology Physics , vol.82 , Issue.2 , pp. 877-882
    • King, C.R.1    Brooks, J.D.2    Gill, H.3    Presti, Jr.J.C.4
  • 64
    • 79951642431 scopus 로고    scopus 로고
    • Acute toxicity after cyberknife-delivered hypofractionated radiotherapy for treatment of prostate cancer
    • 2-s2.0-79951642431 10.1097/COC.0b013e3181c4c7c4
    • Townsend N. C., Huth B. J., Ding W., Garber B., Mooreville M., Arrigo S., Lamond J., Brady L. W., Acute toxicity after cyberknife-delivered hypofractionated radiotherapy for treatment of prostate cancer. American Journal of Clinical Oncology 2011 34 1 6 10 2-s2.0-79951642431 10.1097/COC. 0b013e3181c4c7c4
    • (2011) American Journal of Clinical Oncology , vol.34 , Issue.1 , pp. 6-10
    • Townsend, N.C.1    Huth, B.J.2    Ding, W.3    Garber, B.4    Mooreville, M.5    Arrigo, S.6    Lamond, J.7    Brady, L.W.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.